Laxatives Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027Price: 3200/- USD | Published Date: September 8, 2020 |
The global laxatives drugs market has been projected to grow at the CAGR of 5.6% market during 2020-2027. In 2019, the global laxatives market has a generated revenue of around $ 6 billion and it is expected to reach up to $ 8,098.9 million in terms of revenue by 2025.
The laxatives market is expected to show significant growth during the forecast period on account of increasing demand for laxatives globally due to modern dietary habits, rising geriatric population, increase in consumption of low fiber diet, easy availability of laxatives as over the counter medicines without prescription would influence the growth of laxatives market worldwide.
The global laxatives market is anticipated to grow significantly during the forecast period due to an increase in healthcare awareness, rising geriatric population, and modern unhealthy dietary habits. It is observed that more than 20 percent of the general population is affected with constipation; however, it is more prevalent in the geriatric population and in females. It is studied that psyllium is most widely used in the laxative market due to its cost-effectiveness, safety, and ease of consumption are the prime factors driving the growth of psyllium globally. However, restricted use in the treatment of severe constipation negatively impacting the growth of the psyllium market. It is observed that OTC drugs held the largest market share because the prescribed medication is generally taken for severe constipation in developed countries. OTC drugs such as psyllium derived laxatives, magnesium hydroxide products are widely accepted in developing market. Currently, North America is expected to be the largest regional market for laxatives due to the factors such as the rising geriatric population, the higher number of obese population and modern unhealthy dietary habits are driving the growth of laxatives in North America.
Market Segment Insights:
For the purpose of study global laxative market is studied for drug type and prescription type. Senna, Bisacodyl, Docusate, Polyethylene Glycol 3350, Psyllium, Methylcellulose, Pipeline drug analysis (BLI 801) and other laxatives are marketed drugs primarily considered in drug segment. On the other hand, on the basis of the type of prescription market is segmented as prescribed drugs and over the counter drugs.
Global Laxatives Market Segmentation:
By Drug Type, 2018–2027 ($ Million)
- Polyethylene Glycol 3350
- Pipeline Drug Analysis: BLI 801
By Prescription Type, 2018–2027 ($ Million)
- Prescription Drugs
- Over the Counter Drugs
By Geography, 2018-2027 ($ Million)
- North America
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
For the purpose of this study, the global laxatives market is regionally categorized into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa markets. These regional markets are further sub-segmented into top country-level markets that majorly determine the regional industry trends. Among the considered regional markets, North America and Europe are currently dominating the global laxatives market with the United States being the largest county-level market due to the higher prevalence of constipation, increase in geriatric population and modern unhealthy dietary habits are driving the growth of laxatives in this region. On the other hand, Asia Pacific is anticipated to be the fastest-growing market due to increasing healthcare awareness, improvement in economic conditions and limited treatment availability are the most prominent market drivers in Asia pacific.
Market Competition Assessment:
The major players currently operating in the global IBS-C drugs market include AstraZeneca plc., Bayer AG, Boehringer Ingelheim Pharmaceuticals, Inc., Braintree Laboratories, Ferring Pharmaceuticals, GlaxoSmithKline Consumer Healthcare, L.P., Purdue Pharma, Salix Pharmaceuticals, Sucampo Pharmaceuticals, Inc.
List of Key Companies:
- AstraZeneca plc.
- Bayer AG
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Braintree Laboratories
- Ferring Pharmaceuticals
- GlaxoSmithKline Consumer Healthcare, L.P.
- Purdue Pharma
- Salix Pharmaceuticals
- Sucampo Pharmaceuticals, Inc.
Request a free report sample @ https://www.researchcorridor.com/request-sample/?id=53857
Table of Content:
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Laxatives Market Portraiture
2.2 Global Laxatives Market, by Drug Type, 2019 ($ Million)
2.3 Global Laxatives Market, by Prescription Type, 2019 ($ Million)
2.4 Global Laxatives Market, by Geography, 2019 (Value %)
Chapter 3 Global Laxatives Market Analysis
3.1 Global Laxatives Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.3 Attractive Investment Proposition, 2019
3.4 Competitive Landscape Assessment, by Key Market Players
Chapter 4 Global Laxatives Market Analysis, by Drug Type, 2018-2027 ($ Million)
4.5 Polyethylene Glycol 3350
4.7 Pipeline Drug Analysis: BLI 801
Chapter 5 Global Laxatives Market Analysis, by Prescription Type 2018-2027 ($ Million)
5.2 Prescribed Drugs
5.3 Over the Counter Drugs
Chapter 6 Global Laxatives Market, by Geography, 2018-2027 ($ Million)
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan, and Rest of APAC)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)
Chapter 7 Company Profiles
7.1 AstraZeneca plc.
7.2 Bayer AG
7.3 Boehringer Ingelheim Pharmaceuticals, Inc.
7.4 Braintree Laboratories
7.5 Ferring Pharmaceuticals
7.6 GlaxoSmithKline Consumer Healthcare, L.P.
7.7 Purdue Pharma
7.8 Salix Pharmaceuticals
7.9 Sucampo Pharmaceuticals, Inc.
7.10 Other Major Players
$4800/- Multi User License $6400/- Corporate License
- Markets in over 150 countries analyzed granularly
- 35% of our total client are returning clients
- 100,000+ data points in our comprehensive database
- 24x5 availability - we are always there when you need us
- Our expert team will assist you with all research need and customization
- Our expert research analysts will resolve your every query before and after purchasing the report
- We focus on the accuracy and quality of the report
- Our analyst will provide deep insights into the report
Call Us: +1 520-686-7060